Publication:
Patterns of lymph node involvement for oral cavity squamous cell carcinoma.

cris.virtual.author-orcid0000-0003-0948-1392
cris.virtualsource.author-orcid77241cdc-4d8c-4d18-9987-58a73b2097d1
cris.virtualsource.author-orcid3d7076a2-8835-49ed-8d2f-794a5ccd91e1
cris.virtualsource.author-orcid900188c6-9c50-40ae-91fc-67f39e89ffd7
cris.virtualsource.author-orcid86655b3e-7b2d-49ef-959d-01183a03e32b
datacite.rightsmetadata.only
dc.contributor.authorLudwig, Roman
dc.contributor.authorWerlen, Sandrine
dc.contributor.authorBarbatei, Dorothea
dc.contributor.authorWidmer, Lars
dc.contributor.authorPouymayou, Bertrand
dc.contributor.authorBalermpas, Panagiotis
dc.contributor.authorEliçin, Olgun
dc.contributor.authorDettmer, Matthias
dc.contributor.authorZrounba, Philippe
dc.contributor.authorGiger, Roland
dc.contributor.authorGrégoire, Vincent
dc.contributor.authorSchubert, Adrian
dc.contributor.authorUnkelbach, Jan
dc.date.accessioned2024-10-26T18:42:00Z
dc.date.available2024-10-26T18:42:00Z
dc.date.issued2024-11
dc.description.abstractAIM Whereas the prevalence of lymph node level (LNL) involvement in oral cavity squamous cell carcinomas (OCSCC) has been reported, the details of lymphatic progression patterns are insufficiently quantified. We investigate how the risk of metastases in each LNL depends on the involvement of adjacent LNLs, T-category, subsite, primary tumor lateralization, and other risk factors. METHODS We retrospectively analyzed patients with newly diagnosed OCSCC from two institutions, totaling 348 patients. Involvement of LNLs I-V was recorded individually based on pathology after neck dissection with clinicopathological factors. The dataset is publicly available in a previously developed web-app, which allows querying patients with specific combinations of co-involved LNLs and tumor characteristics. RESULTS Ipsilateral involvement prevalence of levels I-III was higher for advanced T-category (T3/T4) patients (32 %, 38 %, 14 %) compared to early (T1/T2) patients (14 %, 23 %, 11 %). Involvement of level I increased the involvement probability in levels II and III. Similarly, involvement of level II increased the involvement probability in levels I and III. However, there was significant isolated involvement of level I or II. Advanced nodal involvement (>1 LNL involved) was more frequent for patients with extracapsular extension. Overall contralateral involvement in levels I-III was 7 %, 4 %, 3 % and more frequent for more advanced ipsilateral involvement and for midline-crossing tumors. Involvement of levels IV and V was rare: 3 % ipsilateral and 1 % contralateral in both levels. CONCLUSIONS Detailed quantification of LNL involvement in OCSCC depending on involvement of adjacent LNLs and clinicopathological factors may allow further personalizing guidelines on elective nodal treatment.
dc.description.sponsorshipUniversitätsklinik für Radio-Onkologie
dc.description.sponsorshipInstitut für Gewebemedizin und Pathologie
dc.description.sponsorshipUniversitätsklinik für Hals-, Nasen- und Ohrenkrankheiten, Kopf- und Halschirurgie (HNOK)
dc.identifier.pmid39128626
dc.identifier.publisherDOI10.1016/j.radonc.2024.110474
dc.identifier.urihttps://boris-portal.unibe.ch/handle/20.500.12422/179698
dc.language.isoen
dc.publisherElsevier Scientific Publ. Ireland
dc.relation.ispartofRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
dc.relation.issn1879-0887
dc.relation.organizationDCD5A442BB1BE17DE0405C82790C4DE2
dc.relation.organizationDCD5A442BF89E17DE0405C82790C4DE2
dc.relation.organizationDCD5A442BAD6E17DE0405C82790C4DE2
dc.subjectCarcinoma Extranodal extension Lymph nodes Mouth neoplasms Neck dissection Prevalence Retrospective studies Risk factors Squamous cell Squamous cell carcinoma of head and neck
dc.subject.ddc600 - Technology::610 - Medicine & health
dc.subject.ddc500 - Science::570 - Life sciences; biology
dc.titlePatterns of lymph node involvement for oral cavity squamous cell carcinoma.
dc.typearticle
dspace.entity.typePublication
oaire.citation.startPage110474
oaire.citation.volume200
oairecerif.author.affiliationUniversitätsklinik für Radio-Onkologie
oairecerif.author.affiliationInstitut für Gewebemedizin und Pathologie
oairecerif.author.affiliationUniversitätsklinik für Hals-, Nasen- und Ohrenkrankheiten, Kopf- und Halschirurgie (HNOK)
oairecerif.author.affiliationUniversitätsklinik für Hals-, Nasen- und Ohrenkrankheiten, Kopf- und Halschirurgie (HNOK)
unibe.contributor.equalauthtrue
unibe.contributor.equalauthtrue
unibe.contributor.equalauthtrue
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.description.ispublishedpub
unibe.eprints.legacyId199640
unibe.journal.abbrevTitleRadiother Oncol
unibe.refereedtrue
unibe.subtype.articlejournal

Files

Collections